Neutropenia News and Research

RSS
Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils, the most important type of white blood cell, in the blood.
FDA extends indication of metastatic breast cancer treatment to include male patients

FDA extends indication of metastatic breast cancer treatment to include male patients

Best proven drug to treat schizophrenia could be safely given to African descent people

Best proven drug to treat schizophrenia could be safely given to African descent people

When genomic sequencing fails to diagnose a rare disease

When genomic sequencing fails to diagnose a rare disease

FDA approves new treatment for AML patients

FDA approves new treatment for AML patients

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus announces availability of Arsenic Trioxide Injection in the US

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Elderly LS-SCLC patients show similar results to younger counterparts for concurrent chemo-radiotherapy

Elderly LS-SCLC patients show similar results to younger counterparts for concurrent chemo-radiotherapy

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Study reveals safety, efficacy of brexpiprazole for schizophrenia patients with severe psychotic symptoms

Drugs approved for breast cancer treatment are effective and well tolerated in men

Drugs approved for breast cancer treatment are effective and well tolerated in men

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Genentech’s combination therapy improves outcome in patients with non-squamous non-small cell lung cancer

Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients

Maintenance therapy with olaparib improves progression-free survival in advanced ovarian cancer patients

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Immunotherapy increases survival in some patients with metastatic triple negative breast cancer

Immunotherapy increases survival in some patients with metastatic triple negative breast cancer

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

NCCN adds COPIKTRA capsules to NCCN Guidelines for follicular lymphoma

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Verastem Oncology selects US Bioservices to dispense COPIKTRA capsules

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC

Pfizer announces FDA approval of VIZIMPRO for first-line treatment of EGFR-mutated metastatic NSCLC